Fig. 1
PFS of advanced or recurrent GIST patients who received imatinib treatment. A PFS of all GIST patients. B PFS of GIST patients by primary site. C PFS of GIST patients by genetic alterations
Fig. 1 | BMC Cancer
PFS of advanced or recurrent GIST patients who received imatinib treatment. A PFS of all GIST patients. B PFS of GIST patients by primary site. C PFS of GIST patients by genetic alterations